Diabetic nephropathy

被引:0
|
作者
Menne, J. [1 ]
Haller, H. [1 ]
机构
[1] Hannover Med Sch, D-30625 Hannover, Germany
来源
INTERNIST | 2011年 / 52卷 / 05期
关键词
Albuminuria; Hypertension; HbA(1c); Renin angiotensin system; Diabetic nephropathy; STRUCTURAL-FUNCTIONAL RELATIONSHIPS; CARDIOVASCULAR EVENTS; RENAL-DISEASE; MICROALBUMINURIA; INTERVENTION; METAANALYSIS; ALBUMINURIA; PROTEINURIA; PREVENTION; MORTALITY;
D O I
10.1007/s00108-010-2761-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is the most common cause of end-stage renal disease. Since the disease progresses very slowly and usually takes more than 20 years before terminal renal failure occurs, early intervention is of great importance in order to prevent this disabling complication. A good control of diabetes with HbA(1c) levels around 7% is desirable. At least as important is the treatment of elevated blood pressure values. The target value for patients with diabetes has been adjusted in the last year and is now 130-139/80-85 mmHg. Should (micro-)albuminuria or renal insufficiency be present the blood pressure target is < 130/80 mmHg. For the control of hypertension the use of ACE inhibitors or angiotensin receptor blockers is recommended. In addition, the control of other risk factors and appropriate therapeutic intervention is required. A multifactorial intervention leads to the best results and can avoid the occurrence or progression of diabetic kidney disease and other micro- and/or macrovascular complications.
引用
收藏
页码:495 / +
页数:8
相关论文
共 50 条
  • [41] Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
    Lin, Wenwen
    Luo, Yayong
    Liu, Fang
    Li, Hangtian
    Wang, Qian
    Dong, Zheyi
    Chen, Xiangmei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study
    Hata, Shinnosuke
    Ushigome, Emi
    Hosomi, Yukako
    Yoshimura, Takashi
    Takegami, Maya
    Kitagawa, Nobuko
    Tanaka, Toru
    Hasegawa, Goji
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    HYPERTENSION RESEARCH, 2023, 46 (03) : 565 - 574
  • [43] Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy
    Ahmadi, Nooshin
    Amouzegar, Atefeh
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (01) : 1 - 8
  • [44] A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes
    Okada, Hiroshi
    Fukui, Michiaki
    Tanaka, Muhei
    Matsumoto, Shinobu
    Iwase, Hiroya
    Kobayashi, Kanae
    Asano, Mai
    Yamazaki, Masahiro
    Hasegawa, Goji
    Nakamura, Naoto
    ATHEROSCLEROSIS, 2013, 230 (02) : 198 - 201
  • [45] Evaluation of serum adiponectin levels in diabetic nephropathy
    Alnaggar, Alshaimaa Rezk L. R.
    Sayed, Mohamed
    El-deena, Kareem Essam
    Gomaa, Mohamed
    Hamed, Yousra
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 128 - 131
  • [46] Terpenoids in Diabetic Nephropathy: Advances and Therapeutic Opportunities
    Kaushik, Manish
    Kaushik, Aditi
    Chaudhary, Jasmine
    Jain, Akash
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024, 24 (01) : 13 - 30
  • [47] Genetics of Diabetic Nephropathy: a Long Road of Discovery
    Amy Jayne McKnight
    Seamus Duffy
    Alexander P. Maxwell
    Current Diabetes Reports, 2015, 15
  • [48] Risk factors for development of diabetic nephropathy: a review
    Strojek, K
    Grzeszczak, W
    Ritz, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 : 24 - 26
  • [49] Diabetic nephropathy: prevalence, pathogenesis and signalling pathways
    Chintala, Swetha Bindu
    Ganta, Suhasin
    CURRENT SCIENCE, 2023, 124 (08): : 899 - 909
  • [50] Diabetic nephropathy and inflammation
    Duran-Salgado, Montserrat B.
    Rubio-Guerra, Alberto F.
    WORLD JOURNAL OF DIABETES, 2014, 5 (03): : 393 - 398